Merck Manual

Please confirm that you are a health care professional

honeypot link

Dyspepsia

By

Jonathan Gotfried

, MD, Lewis Katz School of Medicine at Temple University

Last full review/revision Jan 2022
Click here for Patient Education
Topic Resources

Dyspepsia: A Manual of Patient Symptoms podcast

Dyspepsia is a sensation of pain or discomfort in the upper abdomen; it often is recurrent. It may be described as indigestion, gassiness, early satiety, postprandial fullness, gnawing, or burning.

Etiology of Dyspepsia

Table
icon

Nonulcer dyspepsia (functional dyspepsia) is defined as dyspeptic symptoms in a patient who has no abnormalities on physical examination and upper gastrointestinal (GI) endoscopy and/or other evaluation (eg, laboratory tests, imaging).

Evaluation of Dyspepsia

History

History of present illness should elicit a clear description of the symptoms, including whether they are acute or chronic and recurrent. Other elements include timing and frequency of recurrence, any difficulty swallowing, and relationship of symptoms to eating or taking drugs. Factors that worsen symptoms (particularly exertion, certain foods, or alcohol) or relieve them (particularly eating or taking antacids) are noted.

Review of systems seeks concomitant GI symptoms such as anorexia, nausea, vomiting, hematemesis, weight loss, and bloody or black (melanotic) stools. Other symptoms include dyspnea and diaphoresis.

Past medical history should include known GI and cardiac diagnoses, cardiac risk factors (eg, hypertension, hypercholesterolemia), and the results of previous tests that have been done and treatments that have been tried. Drug history should include prescription and illicit drug use as well as alcohol.

Physical examination

Review of vital signs should note presence of tachycardia or irregular pulse.

General examination should note presence of pallor or diaphoresis, cachexia, or jaundice. Abdomen is palpated for tenderness, masses, and organomegaly. Rectal examination is done to detect gross or occult blood.

Red flags

The following findings are of particular concern:

  • Acute episode with dyspnea, diaphoresis, or tachycardia

  • Anorexia

  • Nausea or vomiting

  • Weight loss

  • Blood in the stool

  • Dysphagia or odynophagia

  • Failure to respond to therapy with H2 blockers or proton pump inhibitors (PPIs)

Interpretation of findings

A patient presenting with a single, acute episode of dyspepsia is of concern, particularly if symptoms are accompanied by dyspnea, diaphoresis, or tachycardia; such patients may have acute coronary ischemia. Chronic symptoms that occur with exertion and are relieved by rest may represent angina.

GI causes are most likely to manifest as chronic complaints. Symptoms are sometimes classified as ulcer-like, dysmotility-like, or reflux-like; these classifications suggest but do not confirm an etiology. Ulcer-like symptoms consist of pain that is localized in the epigastrium, frequently occurs before meals, and is partially relieved by food, antacids, or H2 blockers. Dysmotility-like symptoms consist of early satiety, postprandial fullness, nausea, vomiting, bloating, and symptoms that are worsened by food and typically not pain. Reflux-like symptoms consist of heartburn or acid regurgitation. However, symptoms often overlap.

Testing

Patients in whom symptoms suggest acute coronary ischemia, particularly those with risk factors, should be sent to the emergency department for urgent evaluation, including ECG and serum cardiac markers. Tests for cardiac disorders should precede tests for GI disorders such as endoscopy.

For patients with chronic, nonspecific symptoms, routine tests include complete blood count (to exclude anemia caused by GI blood loss), routine blood chemistries, and possibly testing for celiac disease Diagnosis Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... read more Diagnosis . If results are abnormal, additional tests (eg, imaging studies, endoscopy) should be considered. Because of the risk of cancer, patients > 60 and those with new-onset red flag findings should undergo upper GI endoscopy. For patients 60 with no red flag findings, some authorities recommend empiric therapy for 4 to 8 weeks with antisecretory agents (eg, PPIs) followed by endoscopy in treatment failures. Others recommend screening for H. pylori infection with a 13C- or 14C-labeled urea breath test or stool assay (see Noninvasive tests Noninvasive tests Helicobacter pylori is a common gastric pathogen that causes gastritis, peptic ulcer disease, gastric adenocarcinoma, and low-grade gastric lymphoma. Infection may be asymptomatic or result... read more ). However, caution is required in using H. pylori or any other nonspecific findings to explain symptoms.

Treatment of Dyspepsia

Specific conditions are treated. Patients without identifiable conditions are observed over time and reassured. Symptoms are treated with PPIs, H2 blockers, or a cytoprotective agent (see Table: Some Oral Drugs for Dyspepsia Some Oral Drugs for Dyspepsia Dyspepsia: A Manual of Patient Symptoms podcast Dyspepsia is a sensation of pain or discomfort in the upper abdomen; it often is recurrent. It may be described as indigestion, gassiness, early... read more ). Prokinetic drugs (eg, metoclopramide, erythromycin) given as a liquid suspension also may be tried in patients with dysmotility-like dyspepsia. However, there is no clear evidence that matching the drug class to the specific symptoms (eg, reflux vs dysmotility) makes a difference. Misoprostol and anticholinergics are not effective in functional dyspepsia. Drugs that alter sensory perception (eg, tricyclic antidepressants) may be helpful.

Table
icon

Key Points

  • Coronary ischemia is possible in a patient with acute “gas.”

  • Endoscopy is indicated for patients > 60 or with red flag findings.

  • Empiric treatment with an acid blocker is reasonable for patients 60 without red flag findings; patients who do not respond in 4 to 8 weeks require further evaluation.

Drugs Mentioned In This Article

Drug Name Select Trade
ERY-TAB, ERYTHROCIN
PREMARIN
LIORESAL
OSMITROL, RESECTISOL
CHOLAC
No US brand name
REGLAN
NEURONTIN
No US brand name
QUALAQUIN
COLCRYS
ALLI, XENICAL
CYTOTEC
DEXILANT
TYLENOL
NEXIUM
PREVACID
PRILOSEC
PROTONIX
ACIPHEX
TAGAMET HB
DILANTIN
COUMADIN
VALIUM
PEPCID
AXID AR
No US brand name
CARAFATE
CILOXAN, CIPRO
LANOXIN
No US brand name
OCUFLOX
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read
Test your knowledge
Eosinophilic Esophagitis
Eosinophilic esophagitis is a chronic immune-mediated disease of the esophagus resulting in eosinophil-predominant inflammation of the esophagus. It can begin at any time between infancy and young adulthood and occasionally manifests in adults. Which of the following symptoms of this disorder is common in most adult patients?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
TOP